333 related articles for article (PubMed ID: 25581599)
1. Pheochromocytoma and paraganglioma in cyanotic congenital heart disease.
Opotowsky AR; Moko LE; Ginns J; Rosenbaum M; Greutmann M; Aboulhosn J; Hageman A; Kim Y; Deng LX; Grewal J; Zaidi AN; Almansoori G; Oechslin E; Earing M; Landzberg MJ; Singh MN; Wu F; Vaidya A
J Clin Endocrinol Metab; 2015 Apr; 100(4):1325-34. PubMed ID: 25581599
[TBL] [Abstract][Full Text] [Related]
2. Pheochromocytoma and paraganglioma in patients with neurofibromatosis type 1.
Gruber LM; Erickson D; Babovic-Vuksanovic D; Thompson GB; Young WF; Bancos I
Clin Endocrinol (Oxf); 2017 Jan; 86(1):141-149. PubMed ID: 27460956
[TBL] [Abstract][Full Text] [Related]
3. Co-Occurrence of Pheochromocytoma-Paraganglioma and Cyanotic Congenital Heart Disease: A Case Report and Literature Review.
Zhao B; Zhou Y; Zhao Y; Zhao Y; Wu X; Bi Y; Luo Y; Ji Z; Rong S
Front Endocrinol (Lausanne); 2018; 9():165. PubMed ID: 29719528
[TBL] [Abstract][Full Text] [Related]
4. Special situations in pheochromocytomas and paragangliomas: pregnancy, metastatic disease, and cyanotic congenital heart diseases.
Araujo-Castro M; Nattero Chavez L; Martínez Lorca A; Molina-Cerrillo J; Alonso-Gordoa T; Pascual-Corrales E
Clin Exp Med; 2022 Aug; 22(3):359-370. PubMed ID: 34591219
[TBL] [Abstract][Full Text] [Related]
5. Comparison of plasma metanephrines in patients with cyanotic and acyanotic congenital heart disease.
Jensterle M; Podbregar A; Janež A; Rakusa M; Goricar K; Prokšelj K
Endocrine; 2022 Dec; 78(3):580-586. PubMed ID: 36194345
[TBL] [Abstract][Full Text] [Related]
6. Clinical Predictors of Malignancy in Patients with Pheochromocytoma and Paraganglioma.
Dhir M; Li W; Hogg ME; Bartlett DL; Carty SE; McCoy KL; Challinor SM; Yip L
Ann Surg Oncol; 2017 Nov; 24(12):3624-3630. PubMed ID: 28884434
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous genetic background of the association of pheochromocytoma/paraganglioma and pituitary adenoma: results from a large patient cohort.
Dénes J; Swords F; Rattenberry E; Stals K; Owens M; Cranston T; Xekouki P; Moran L; Kumar A; Wassif C; Fersht N; Baldeweg SE; Morris D; Lightman S; Agha A; Rees A; Grieve J; Powell M; Boguszewski CL; Dutta P; Thakker RV; Srirangalingam U; Thompson CJ; Druce M; Higham C; Davis J; Eeles R; Stevenson M; O'Sullivan B; Taniere P; Skordilis K; Gabrovska P; Barlier A; Webb SM; Aulinas A; Drake WM; Bevan JS; Preda C; Dalantaeva N; Ribeiro-Oliveira A; Garcia IT; Yordanova G; Iotova V; Evanson J; Grossman AB; Trouillas J; Ellard S; Stratakis CA; Maher ER; Roncaroli F; Korbonits M
J Clin Endocrinol Metab; 2015 Mar; 100(3):E531-41. PubMed ID: 25494863
[TBL] [Abstract][Full Text] [Related]
8. Pheochromocytoma and paraganglioma in Fontan patients: Common more than expected.
Song MK; Kim GB; Bae EJ; Lee YA; Kim HY; Min SK; Kim JH; Won JK
Congenit Heart Dis; 2018 Jul; 13(4):608-616. PubMed ID: 30033572
[TBL] [Abstract][Full Text] [Related]
9. Malignant pheochromocytoma and paraganglioma: a population level analysis of long-term survival over two decades.
Goffredo P; Sosa JA; Roman SA
J Surg Oncol; 2013 May; 107(6):659-64. PubMed ID: 23233320
[TBL] [Abstract][Full Text] [Related]
10. A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma.
Waguespack SG; Rich T; Grubbs E; Ying AK; Perrier ND; Ayala-Ramirez M; Jimenez C
J Clin Endocrinol Metab; 2010 May; 95(5):2023-37. PubMed ID: 20215394
[TBL] [Abstract][Full Text] [Related]
11. Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites?
Grouzmann E; Tschopp O; Triponez F; Matter M; Bilz S; Brändle M; Drechser T; Sigrist S; Zulewski H; Henzen C; Fischli S; Abid K
PLoS One; 2015; 10(5):e0125426. PubMed ID: 25946206
[TBL] [Abstract][Full Text] [Related]
12. CHARACTERISTICS AND OUTCOMES OF METASTATIC SDHB AND SPORADIC PHEOCHROMOCYTOMA/PARAGANGLIOMA: AN NATIONAL INSTITUTES OF HEALTH STUDY.
Turkova H; Prodanov T; Maly M; Martucci V; Adams K; Widimsky J; Chen CC; Ling A; Kebebew E; Stratakis CA; Fojo T; Pacak K
Endocr Pract; 2016 Mar; 22(3):302-14. PubMed ID: 26523625
[TBL] [Abstract][Full Text] [Related]
13. Clinical Aspects of SDHA-Related Pheochromocytoma and Paraganglioma: A Nationwide Study.
van der Tuin K; Mensenkamp AR; Tops CMJ; Corssmit EPM; Dinjens WN; van de Horst-Schrivers ANA; Jansen JC; de Jong MM; Kunst HPM; Kusters B; Leter EM; Morreau H; van Nesselrooij BMP; Oldenburg RA; Spruijt L; Hes FJ; Timmers HJLM
J Clin Endocrinol Metab; 2018 Feb; 103(2):438-445. PubMed ID: 29177515
[TBL] [Abstract][Full Text] [Related]
14. Genotype-Phenotype Features of Germline Variants of the TMEM127 Pheochromocytoma Susceptibility Gene: A 10-Year Update.
Armaiz-Pena G; Flores SK; Cheng ZM; Zhang X; Esquivel E; Poullard N; Vaidyanathan A; Liu Q; Michalek J; Santillan-Gomez AA; Liss M; Ahmadi S; Katselnik D; Maldonado E; Salgado SA; Jimenez C; Fishbein L; Hamidi O; Else T; Lechan R; Tischler AS; Benn DE; Dwight T; Clifton-Bligh R; Sanso G; Barontini M; Vincent D; Aronin N; Biondi B; Koops M; Bowhay-Carnes E; Gimenez-Roqueplo AP; Alvarez-Eslava A; Bruder JM; Kitano M; Burnichon N; Ding Y; Dahia PLM
J Clin Endocrinol Metab; 2021 Jan; 106(1):e350-e364. PubMed ID: 33051659
[TBL] [Abstract][Full Text] [Related]
15. First report of bilateral pheochromocytoma in the clinical spectrum of HIF2A-related polycythemia-paraganglioma syndrome.
Taïeb D; Yang C; Delenne B; Zhuang Z; Barlier A; Sebag F; Pacak K
J Clin Endocrinol Metab; 2013 May; 98(5):E908-13. PubMed ID: 23539726
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the insulin-like growth factor 1 receptor (IGF-1R) is associated with malignancy in familial pheochromocytomas and paragangliomas.
Fernandez MC; Martin A; Venara M; Calcagno Mde L; Sansó G; Quintana S; Chemes HE; Barontini M; Pennisi PA
Clin Endocrinol (Oxf); 2013 Nov; 79(5):623-30. PubMed ID: 23506534
[TBL] [Abstract][Full Text] [Related]
17. Genetic Analysis of Pheochromocytoma and Paraganglioma Complicating Cyanotic Congenital Heart Disease.
Ogasawara T; Fujii Y; Kakiuchi N; Shiozawa Y; Sakamoto R; Ogawa Y; Ootani K; Ito E; Tanaka T; Watanabe K; Yoshida Y; Kimura N; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Ogawa S
J Clin Endocrinol Metab; 2022 Aug; 107(9):2545-2555. PubMed ID: 35730597
[TBL] [Abstract][Full Text] [Related]
18. A Case of Paraganglioma with Cyanotic Congenital Heart Disease.
Wahab NA; Chien BH; Omar MR; Aziz AA; Mustafa N; Sukor N; Kamaruddin NA
Acta Med Indones; 2021 Jan; 53(1):77-81. PubMed ID: 33818409
[TBL] [Abstract][Full Text] [Related]
19. Peripheral neuroblastic tumors and congenital heart disease. Possible role of hypoxic states in tumor induction.
de la Monte SM; Hutchins GM; Moore GW
Am J Pediatr Hematol Oncol; 1985; 7(2):109-16. PubMed ID: 3842556
[TBL] [Abstract][Full Text] [Related]
20. [Pediatric pheochromocytoma and paraganglioma: an update].
Garnier S; Réguerre Y; Orbach D; Brugières L; Kalfa N
Bull Cancer; 2014 Oct; 101(10):966-75. PubMed ID: 25373696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
